November 11,2020: Drug major Glenmark Pharma para Wednesday te koikena janaishe US health regulator para final approval paishe Tacrolimus capsules immuno-suppressant nishena chulabole nimete .etu approved kura produc toh ekta generic version ase Prograf Capsules Astellas Pharm US, Inc. Tacrolimus capsule laga thaka toh ekta immunosuppressant ase etu to organ rejection kunba patients khan te nolabole nimete ase etu bi liver, kidney, or heart transplant samay te.
Glenmark para regulatory filling te koikena janaishe ki Glenmark Pharmaceuticals Inc, USA, ke final approval dishe United States Food and Drug Administration (USFDA) Tacrolimus Capsules USP nmete etu bi 0.5 mg, 1 mg and 5 mg, laga strength te.
IQVIA sales data 12 moina te dika hisaab te September 2020 te khotom hoikenna Glenmark koikena janaishe Prograf Capsules, 0.5 mg, 1 mg and 5 mg para market te annual sales komti hoilebi USD 286.8 million kamaishe.
Glenmark koikena janaishe etia laga portfolio te 166 products ase authorised kura toh US marketplace te dibole nimete aro 45 abbreviated new drug applications khan USFDA logote approval nimete rukhikena ase.
Glenmark pharma laga shares tioh Rs 479 per scrip BSE te trade kuri ase etu toh poila laga close para 0.94 per cent uthikena ase.
Add Comment